Search
Rigel Appoints Board Member Dr. Alison L. Hannah as Chief Medical Officer
4 day ago /
Read about 0 minute
Author：小编
Biopharmaceutical company Rigel Pharmaceuticals announced that, effective July 1, 2026, Dr. Alison L. Hannah will be appointed as Executive Vice President and Chief Medical Officer, while resigning from her position as a board member. Dr. Hannah holds a Bachelor's degree in Biochemistry and Immunology from Harvard University and a Medical Doctorate from the University of St Andrews. With over thirty years of experience in the pharmaceutical industry, her transition to an executive role reflects the company's high recognition of her professional capabilities.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
